Pay in 4 interest-free payments of $5.79 Learn more
Ships within 48 hours · Estimated delivery Oct 10 - Oct 15
Licensed indications 2,3 2,3 Subcutaneous semaglutide (Wegovy) and tirzepatide (Mounjaro) are indicated as adjuncts to a reduced-calorie diet and increased physical activity for weight management, including weight loss and weight maintenance, in adults with an initial BMI of: 30 kg/m 2 (obesity), or 27 kg/m 2 to 2 days away, administer as soon as possible
Seek immediate medical attention for severe persistent abdominal pain (especially radiating to the back), persistent vomiting preventing fluid intake, severe right upper abdominal pain suggesting gallbladder disease, or signs of gastrointestinal bleeding
You can inject it in areas such as the abdomen, thigh, or upper arm, with guidance from your provider on proper technique and injection site rotation
You can also use the Aetna medication search tool to find more information
PMID: 31193945
US$ 20.39
US$ 29.92
US$ 27.24
,aspect=ignore)
US$ 24.07
US$ 27.80
US$ 1509.00
Sold : Login>>
